Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
William J. Dupps Jr., MD, PhD, a native of Catawba Island, Ohio, joined the staff of Cleveland Clinic in 2006 and has appointments in Ophthalmology, Biomedical Engineering and Transplantation. He also holds an adjunct appointment as Associate Professor in the Department of Biomedical Engineering at Case Western Reserve University. After graduating with an undergraduate degree in chemical Engineering from Purdue University, he completed his master’s and doctoral degrees in Biomedical Engineering at The Ohio State University, where he also earned his medical degree with honors as a fellow in the Medical Scientist Training Program. He completed an ophthalmology residency at the University of Iowa Department of Ophthalmology and Visual Sciences, a research fellowship in ocular gene therapy at the National Eye Institute, and a two-year Cornea and Refractive Surgery Fellowship at the Cole Eye Institute. He specializes in refractive surgery, corneal transplantation, and cataract surgery.
With funding from the National Keratoconus Foundation, the National Institutes of Health, and a Research to Prevent Blindness Career Development Award, Dr. Dupps leads an interdisciplinary research team in the Ocular Biomechanics and Imaging Laboratory at the Cole Eye Institute focused on the biomechanics of keratoconus and methods for improving refractive surgery outcomes with patient-specific computational modeling. Dr. Dupps is listed in Who’s Who in Medicine and Healthcare, Who’s Who in Science and Engineering, and America’s Top Ophthalmologists, and was named Teacher of the Year by the residents of the Cole Eye Institute in 2010.
Dr. Dupps is Associate Editor of the Journal of Cataract & Refractive Surgery, the leading journal in the field of anterior segment eye surgery, and has authored numerous journal articles and book chapters. He is named on several patents and received the Cleveland Clinic’s first Early Career Innovation Award in 2009.
corneal transplantation & cataract, Refractive Surgery
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 10/6/2013, Dr. Dupps has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Royalty Payments. Dr. Dupps receives or has the right to receive royalty payments for inventions or discoveries commercialized through the companies shown below:
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.